Do Oral Pathogens Cause Systemic Disease? — Part I

Pathologists have found Porphyromonas gingivalis — a bacterium that lives in inflamed gums — inside atherosclerotic plaques, inside Alzheimer's brain tissue, and inside tumor microenvironments. It is one of the most provocative findings in modern oral-systemic research. It is also one of the most easily overstated. The distance between detection and causation is where this module lives.

The question that won't go away

Periodontitis and systemic disease travel together. That much is settled. The real question is sharper: do oral pathogens merely associate with heart disease, dementia, and cancer — or do they contribute mechanistically to them?

The honest answer today is we have strong association and plausible mechanism, but not proof. Holding both of those at once — taking the evidence seriously without inflating it — is the entire discipline of this series.

What the evidence actually supports

There are four independent lines pointing toward pathogen involvement, and they are not weak:

1. Epidemiological association. Periodontitis is significantly associated with atherosclerotic cardiovascular disease (ASCVD) across multiple large cohort studies. This is Established — meta-analysis grade.
2. Bacteria at the scene. P. gingivalis DNA and antigens have been detected in atherosclerotic plaques, in brain tissue in Alzheimer's disease, and in tumor microenvironments.
3. Mechanistic plausibility. There are defined molecular pathways — gingipain proteases, LPS signaling, vesicle-mediated delivery — not vague hand-waving.
4. Intervention signal. Periodontal therapy measurably improves surrogate cardiometabolic markers like endothelial function and inflammatory biomarkers.

The stakes make this worth getting right. Cardiovascular disease causes 32% of global deaths; cancer, roughly 1 in 6; dementia is projected to affect ~1 billion people by 2050. Even a modest, modifiable upstream contribution to diseases at that scale would matter enormously.

The causation gap — stated plainly

Here is where a lesser framework would cheat. This one doesn't.

• Detection is not causation. Finding a bacterium in a plaque tells you it arrived, not that it caused the plaque.
• Animal models show acceleration, not proof. Mouse models of P. gingivalis-accelerated atherosclerosis are suggestive — but mice are not people.
• No prospective interventional trial has shown that treating periodontitis prevents a heart attack, a stroke, a cancer, or a case of dementia.
• Koch's postulates and the Bradford Hill criteria are not fully satisfied.

The opportunity is not to collapse many diseases into one disease. It is to identify shared upstream interfaces worth measuring and testing.

That reframing is the whole game.

Established vs. Hypothesis: the same finding, two tiers

The identical bacterium supports claims at very different confidence levels. Naming the tier is the point:

Claim	Tier
Periodontitis is associated with ASCVD	Established
Periodontal therapy improves inflammatory markers	Established
Oral pathogens cause heart disease, cancer, or Alzheimer's	Hypothesis under test
Treating gums prevents these diseases	Hypothesis under test

Say "associated with." Never say "causes." The evidence licenses the first phrase and forbids the second — and a clinician who blurs them does the science a disservice.

Measure first, claim later

Rather than race to a causal headline, the OVN framework proposes a disciplined path:

Prove an upstream signal, show that intervention moves it, and only then claim disease modification.

This measurement-first strategy is scientifically stronger and, not incidentally, more credible. It says: let's find a signal we can quantify in blood or saliva, demonstrate that periodontal treatment shifts it, and correlate that shift with outcomes — before anyone claims to prevent anything.

The takeaway for the chair

• Oral pathogens have defined molecular mechanisms for systemic effects. Take them seriously.
• The evidence is strong enough to justify attention, not strong enough to claim causation.
• Stay current on this science without overstating it to patients.

Module 46 asked the question — do they? — and answered with rigorous uncertainty. The natural next question is mechanistic: if oral pathogens reach distant organs, how? Intact bacteria are large, conspicuous, and quickly cleared. The answer, taken up in Part II, is something far smaller and far harder to stop.